Abstract
Neglected protozoan diseases as Leishmaniasis and Chagas Disease affect more than 20 million people, mainly in developing countries. Considering the rstricted therapeutic arsenal, toxic and inefficient, new treatments are urgently needed. In the search for new compounds, natural metabolites represent a promising source of pharmaceutical prototypes. The present proposal aims to identify ne…